Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Net Income: 2012-2025

Historic Net Income for Agios Pharmaceuticals (AGIO) over the last 14 years, with Sep 2025 value amounting to -$103.4 million.

  • Agios Pharmaceuticals' Net Income fell 110.91% to -$103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$403.0 million, marking a year-over-year decrease of 160.06%. This contributed to the annual value of $673.7 million for FY2024, which is 291.35% up from last year.
  • Agios Pharmaceuticals' Net Income amounted to -$103.4 million in Q3 2025, which was up 8.09% from -$112.5 million recorded in Q2 2025.
  • Agios Pharmaceuticals' Net Income's 5-year high stood at $2.0 billion during Q1 2021, with a 5-year trough of -$112.5 million in Q2 2025.
  • For the 3-year period, Agios Pharmaceuticals' Net Income averaged around $796,545, with its median value being -$91.3 million (2023).
  • Per our database at Business Quant, Agios Pharmaceuticals' Net Income surged by 4,382.87% in 2021 and then slumped by 2,696.82% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Net Income (Quarterly) stood at $4.0 million in 2021, then plummeted by 2,442.28% to -$92.7 million in 2022, then decreased by 3.51% to -$95.9 million in 2023, then fell by 0.61% to -$96.5 million in 2024, then crashed by 110.91% to -$103.4 million in 2025.
  • Its last three reported values are -$103.4 million in Q3 2025, -$112.5 million for Q2 2025, and -$90.5 million during Q1 2025.